Evidence map›Paper›PMID 41807954›Full record

ArticleCell communication and signaling : CCS2026

Kremen1 dependence receptor induces SEC24C and ATG9A-dependent cell death.

Sonia Brahim, Thomas Schott, Shiva Ghasemi-Firouzabadi, Ana Negulescu, Clara Geneste, Elisabeth Errazuriz-Cerda, Gabriel Ichim, Patrick Mehlen, Olivier Meurette

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sonia Brahim *Cancer Cell Death Laboratory, LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, 69008, France.
Thomas Schott *Apoptosis, Cancer and Development Laboratory- Equipe Labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, 69008, France.
Shiva Ghasemi-Firouzabadi *Cancer Cell Death Laboratory, LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, 69008, France.
Ana NegulescuApoptosis, Cancer and Development Laboratory- Equipe Labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, 69008, France.
Clara GenesteApoptosis, Cancer and Development Laboratory- Equipe Labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, 69008, France.
Elisabeth Errazuriz-CerdaCentre d'Imagerie Quantitative Lyon Est, Université Claude Bernard Lyon1, Lyon, France.
Gabriel IchimCancer Cell Death Laboratory, LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, 69008, France.ORCID http://orcid.org/0000-0002-8386-7405
Patrick MehlenApoptosis, Cancer and Development Laboratory- Equipe Labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, 69008, France.
Olivier MeuretteCancer Cell Death Laboratory, LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, 69008, France. olivier.meurette@lyon.unicancer.fr.ORCID http://orcid.org/0000-0002-1087-5981

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among dependence receptors (DRs), which induce apoptosis when unbound by their cognate ligands, Kremen1 was initially reported to drive cancer cell death in the absence of DKK1. However, the precise mechanism of Kremen1-induced cell death remains unclear. In this study, we demonstrate that Kremen1 induces cell death with autophagic features, contrasting with the apoptotic process typically associated with DRs. Functional experiments using pharmacological inhibition of autophagy or genetic silencing of key autophagy effectors, confirmed this cell death process. Protein–protein proximity assays through biotin labeling identified SEC24C, a component of the COP-II complex, as a critical effector of this process. Moreover, the proximity between Kremen1, SEC24C and ATG9A after vesicular trafficking, fosters the proximity of SEC24C with ATG8, ERGIC and ATG9A, likely increasing the number of autophagosomes and vesicles leading to cell death. Given that the Kremen1/DKK1 pair is frequently altered in cancers, its aberrant induction should be monitored and may be targeted to offer an alternative strategy to treat cancers resistant to current therapies.

Indexed as

Autophagy-Related ProteinsMembrane ProteinsVesicular Transport ProteinsAutophagyCell DeathHumansATG9A protein, humanAutophagy-Related ProteinsMembrane ProteinsVesicular Transport ProteinsATG9ACancerCell deathDependence ReceptorsSEC24C

Identifiers

PMID41807954
PMCPMC13088645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.